Ruano, M.; Flores, A.; Couto, A.; Gaspar, I.; Yerly, S.; Zamudio, A.G.G.; Bene, R.; Maiela, A.; Macuacua, H.; Lane, J.;
et al. Dolutegravir Resistance in Mozambique: Insights from a Programmatic HIV Resistance Testing Intervention in a Highly Antiretroviral Therapy-Experienced Cohort. Infect. Dis. Rep. 2025, 17, 123.
https://doi.org/10.3390/idr17050123
AMA Style
Ruano M, Flores A, Couto A, Gaspar I, Yerly S, Zamudio AGG, Bene R, Maiela A, Macuacua H, Lane J,
et al. Dolutegravir Resistance in Mozambique: Insights from a Programmatic HIV Resistance Testing Intervention in a Highly Antiretroviral Therapy-Experienced Cohort. Infectious Disease Reports. 2025; 17(5):123.
https://doi.org/10.3390/idr17050123
Chicago/Turabian Style
Ruano, Maria, Antonio Flores, Aleny Couto, Irénio Gaspar, Sabine Yerly, Ana Gabriela Gutierrez Zamudio, Rosa Bene, Adelina Maiela, Helder Macuacua, Jeff Lane,
and et al. 2025. "Dolutegravir Resistance in Mozambique: Insights from a Programmatic HIV Resistance Testing Intervention in a Highly Antiretroviral Therapy-Experienced Cohort" Infectious Disease Reports 17, no. 5: 123.
https://doi.org/10.3390/idr17050123
APA Style
Ruano, M., Flores, A., Couto, A., Gaspar, I., Yerly, S., Zamudio, A. G. G., Bene, R., Maiela, A., Macuacua, H., Lane, J., Mudender, F., & Nacarapa, E.
(2025). Dolutegravir Resistance in Mozambique: Insights from a Programmatic HIV Resistance Testing Intervention in a Highly Antiretroviral Therapy-Experienced Cohort. Infectious Disease Reports, 17(5), 123.
https://doi.org/10.3390/idr17050123
